Article Versions Notes

Liao C-K, Kuo Y-T, Chern Y-J, Hsu Y-J, Lin Y-C, Yu Y-L, Hsieh P-S, Chiang J-M, Yeh C-Y, You J-F. Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer. Journal of Clinical Medicine. 2022; 11(10):2920. https://doi.org/10.3390/jcm11102920

Liao, Chun-Kai, Ya-Ting Kuo, Yih-Jong Chern, Yu-Jen Hsu, Yueh-Chen Lin, Yen-Lin Yu, Pao-Shiu Hsieh, Jy-Ming Chiang, Chien-Yuh Yeh, and Jeng-Fu You. 2022. "Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer" Journal of Clinical Medicine 11, no. 10: 2920. https://doi.org/10.3390/jcm11102920

Liao, C.-K., Kuo, Y.-T., Chern, Y.-J., Hsu, Y.-J., Lin, Y.-C., Yu, Y.-L., Hsieh, P.-S., Chiang, J.-M., Yeh, C.-Y., & You, J.-F. (2022). Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer. Journal of Clinical Medicine, 11(10), 2920. https://doi.org/10.3390/jcm11102920